Previous 10 | Next 10 |
2023-12-18 05:43:43 ET Summary The best performance of the bull plateau is to advance steadily, not to move monotonously, and support for loyal cash cows. The article discusses winners in various categories such as Mega-Cap Group, Large-Cap Group, Small-Cap Group, Top Gains, All T...
2023-12-13 11:18:26 ET More on Pfizer Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks Biggest stock movers tod...
Canadians Can Help Protect Loved Ones as We Head into the Holiday Season Canada NewsWire Novavax launches Choose to Protect™ campaign to educate public about importance of updated COVID-19 vaccination Recent survey finds that 70% of Canadians believe in the va...
2023-12-05 16:56:15 ET More on Novavax Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference (Transcript) Novavax: Less Is Less - Shrinking COVID Market Takes Its Toll (Rating Downgrade) Novavax: The COVID Gig Is Over Novavax settles class a...
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada Canada NewsWire Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md. , Dec. 5, 2023 ...
2023-11-28 06:20:57 ET Novavax ( NASDAQ: NVAX ) shares gained 4% premarket on Tuesday after the vaccine maker was granted emergency use listing by the World Health Organization for its updated protein-based COVID-19 vaccine, Nuvaxovid XBB.1.5 Covid-19 Vaccine (NVX-CoV2601). ...
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization PR Newswire GAITHERSBURG, Md. , Nov. 28, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vac...
2023-11-24 12:35:42 ET More on BioNTech, GSK, etc. BioNTech Vs. Moderna: Navigating The mRNA Landscape Pfizer Is A Fantastic Buy And So Are These 9%-Yielding Blue Chips Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade) GSK makes ...
2023-11-17 11:46:02 ET Summary Moderna, Inc. reported weak Covid vaccine sales and cut revenue targets for 2023 and 2024. Covid vaccine demand is lower than predicted, with Moderna now guiding to only 50 million doses this year while demand might dip to only 30 million. The st...
2023-11-17 08:01:25 ET Novavax ( NASDAQ: NVAX ) on Friday announced changes to its leadership team and named John Trizzino to the new role of president and chief operating officer. In the newly created role, Trizzino will lead commercial; chemistry, manufacturing and contr...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...